Bifidobacterium
Bifidobacterium breve BB077 (LMG P-30157), developed by SynBalance.Gastrointestinal Health • Cognitive function• Immune prevention
Bifidobacterium longum subsp. infantis BI221 (LMG P-29639), developed by SynBalance.Gastrointestinal Health • Immune prevention
Bifidobacterium bifidum BBF210 (LMG P-29508), developed by SynBalance.Gastrointestinal Health
Bifidobacterium longum subsp. longum BLG240 (LMG P-29511), developed by SynBalance.Gastrointestinal Health • Immune prevention
Bifidobacterium animalis subsp. lactis BL050 (DSM 25566), developed by SynBalance.Gastrointestinal Health • Urogenital health • Metabolic Health• Immune prevention
The probiotic strain Bifidobacterium lactis Lafti® B94 has been specifically documented in the area of gut health. It benefits from a strong body of clinical evidence, supported by in vitro and in vivo documentation of its…
Restoration of a better dietary ω-6/ω-3 balance • Conjugated linoleic acids (CLA) production • Prospective use in the treatment of obesity • Cholesterol management
Constipation • Intestinal transit • Oxalate degradation • Reduction of intestinal inflammation • Potential reduction of kidney stones incidence
Reduction of gastro-intestinal discomfort related to IBS • Rebalance of intestinal microbiota • Non-transmissible rifamycins resistance • Production of Exopolysaccharides • Hepatic encephalopathy
Cardiovascular health • Cholesterol lowering
